文献速递炎症性肠病消化内镜

内镜与组织学活动度对溃疡性结肠炎疾病复发的影响

Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
PubMed 文献 · Am J Gastroenterol · 2022-07-21

在麦吉尔大学健康中心开展的前瞻性观察研究中,纳入253例临床缓解至少3个月的溃疡性结肠炎成人患者,评估组织学缓解相对于内镜缓解的额外获益。基线浆细胞增多与复发相关(校正比值比=2.07,95%CI 1.06-4.18,P=0.042);Mayo内镜评分>0者临床复发时间显著更长(校正风险比=2.65,95%CI 1.31-5.39,P=0.007);Geboes评分≥3.1者临床复发时间无显著差异(校正风险比=1.29,95%CI 0.67-2.49,P=0.45)。

要点

  • 基线浆细胞增多与溃疡性结肠炎复发相关(校正比值比=2.07,95%CI 1.06-4.18,P=0.042)。
  • Mayo内镜评分>0者临床复发时间显著更长(校正风险比=2.65,95%CI 1.31-5.39,P=0.007)。
  • Geboes评分≥3.1者临床复发时间无显著差异(校正风险比=1.29,95%CI 0.67-2.49,P=0.45)。

核心结论

  • 在达到内镜缓解的溃疡性结肠炎患者中,活动性组织学病变未影响临床复发时间,而基线浆细胞增多与复发相关。

研究设计与样本

  • 在麦吉尔大学健康中心开展的前瞻性观察研究,纳入253例临床缓解至少3个月并接受结肠镜检查的溃疡性结肠炎成人患者。

主要发现

  • 基线浆细胞增多与复发相关(校正比值比=2.07,95%CI 1.06-4.18,P=0.042)。
  • Mayo内镜评分>0者临床复发时间显著更长(校正风险比=2.65,95%CI 1.31-5.39,P=0.007)。
  • Geboes评分≥3.1者临床复发时间无显著差异(校正风险比=1.29,95%CI 0.67-2.49,P=0.45)。

关键数值与推荐

  • 内镜活动度采用Mayo内镜评分评估。
  • 组织学活动度采用Geboes评分评估,活动性疾病定义为Geboes评分≥3.1,并评估基底浆细胞增多。
  • 复发定义为部分Mayo评分>2。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Endoscopic healing is currently considered the main target in the management of ulcerative colitis (UC). There are conflicting data about the role of histology as a stricter treatment objective. We aim at evaluating the additional benefit of histologic remission over endoscopic remission. METHODS: We performed a prospective observational study at the McGill University Health Center. We enrolled adult patients with UC in clinical remission for at least 3 months undergoing a colonoscopy. Endoscopic disease activity was based on the Mayo endoscopic score. Rectal biopsies were obtained, and the histologic activity was evaluated using the Geboes score (active disease defined as Geboes score ≥ 3.1) with the addition of assessing the presence of basal plasmacytosis. Patients were followed up for 12 months for disease relapse defined as a partial Mayo score of > 2. At the time of relapse or end of follow-up, all patients underwent repeat endoscopic evaluation. The primary end point was clinical relapse. RESULTS: Two hundred fifty-three patients were included. The presence of basal plasmacytosis was associated with relapse (adjusted odd ratio = 2.07, 95% confidence interval [CI] 1.06-4.18, P = 0.042). Time to clinical relapse was significantly higher for patients with Mayo endoscopic score > 0 with adjusted hazard ratio = 2.65, 95% CI 1.31-5.39, and P = 0.007. Time to clinical relapse was not significantly higher for Geboes score ≥ 3.1 with adjusted hazard ratio = 1.29, 95% CI 0.67-2.49, and P = 0.45. DISCUSSION: Active histologic disease did not affect time to clinical relapse in patients with UC who achieved endoscopic remission while the presence of basal plasmacytosis is associated with relapse.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Bessissow T, Kron CM, Marcus V, et al. Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis. Am J Gastroenterol. 2022. PMID: 35862833. doi:10.14309/ajg.0000000000001912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。